Article Details

Biopharma Co. Licenses Orphan Drug to UK Firm for $450M - Streetwise Reports

Retrieved on: 2022-05-05 20:08:02

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Co. Licenses Orphan Drug to UK Firm for $450M - Streetwise Reports. View article details on hiswai:

Excerpt

Intercept Pharmaceuticals is a biopharma firm based in Morriston, N.J. that focuses on developing and commercializing therapeutics for use in ...

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up